key: cord-0863753-stu2ec5x
authors: Liu, Anding; Wang, Wenjie; Zhao, Xuecheng; Zhou, Xiaoxi; Yang, Dongliang; Lu, Mengji; Lv, Yongman
title: Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery
date: 2020-07-09
journal: Clin Microbiol Infect
DOI: 10.1016/j.cmi.2020.07.009
sha: 027c67dc708d0b074288d169df4266fc022f2aa2
doc_id: 863753
cord_uid: stu2ec5x

A newly identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of coronavirus disease 2019 (COVID-19) across the world. An understanding of the antibody responses to the viral components is very important for diagnosis and vaccine development. We herein estimated the longevity of specific antibodies against SARS-CoV-2, and reported antibodies disappeared in a moderate COVID-19 patient within 3 months after the onset of the symptoms.

To the editor, 1 Coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China in 2 December 2019, has caused an international outbreak. A newly isolated severe acute 3 respiratory syndrome coronavirus 2 (SARS-CoV-2) was found to be the etiological 4 agent of COVID-19 [1] . Thus far, there is no specific antiviral treatment reported that antibodies disappeared within 3 months after the onset of the symptoms. of the highest dilution of the serum that CPE was not observed. We found that 9 neutralizing activity was negative (neutralizing antibodies titers <20). To assess this, 10 peripheral blood monocytic cells (PBMCs) were isolated from the whole blood and 

Genomic characterisation and 3 epidemiology of 2019 novel coronavirus: implications for virus origins and 4 receptor binding

Disappearance of antibodies 6 to SARS-associated coronavirus after recovery

Antibody Responses 1 Year after Symptom Onset, South Korea